Heuron
Developer of AI-based medical imaging software for neurovascular and neurodegenerative applications. Builds convolutional neural network models and deployment-ready software that automatically analyze CT and MR brain images to support triage, diagnostic scoring and treatment decisions. Provides on-premise, GPU-accelerated containerized deployments with documented system requirements, publishes safety and clinical performance information, and participates in peer-reviewed validation studies and regulatory conformity processes.
Industries
Nr. of Employees
medium (51-250)
Patents
Apparatus and method for extracting vascular function from brain-related information
US-12026883-B1
View DetailsArtificial intelligence-based devices and methods for geometric alignment and preprocessing of raw CT images
US-11954873-B1
View DetailsIschemic stroke detection and classification method based on medical image, apparatus and system
US-11602322-B2
View DetailsDevice and method for detecting cerebral microbleeds using magnetic resonance images
US-11481902-B2
View Details
Apparatus and method for extracting vascular function from brain-related information
US-12026883-B1
View DetailsArtificial intelligence-based devices and methods for geometric alignment and preprocessing of raw CT images
US-11954873-B1
View DetailsIschemic stroke detection and classification method based on medical image, apparatus and system
US-11602322-B2
View DetailsDevice and method for detecting cerebral microbleeds using magnetic resonance images
US-11481902-B2
View DetailsProducts
MRI nigrosome-1 quantification software
Diagnostic-aid software that analyzes susceptibility-weighted MR images and clinical metadata to detect and quantify nigrosome-1 features for Parkinsonism assessment. Internal performance reported with sensitivity and specificity metrics; documented server requirements for advanced modules are provided.
Automated intracranial hemorrhage triage software
Radiological triage and notification software that identifies suspected intracranial hemorrhage on non-contrast head CT and prioritizes cases for clinical review. Documented performance metrics and scanner-dependent input constraints are provided.
NCCT-based large vessel occlusion classification software
Automatic analysis of non-contrast CT and CTA images to classify suspected large vessel occlusion and predict the probable affected hemisphere to aid rapid triage, with documented performance examples and validation notes.
Automated ASPECTS scoring software
Automated computation of ASPECTS from non-contrast CT using a CNN algorithm to support ischemic stroke assessment; clinical investigation results and container/OS dependencies are documented.
CT perfusion analysis software
Automated CT perfusion analysis that produces color-coded perfusion maps, calculates core/penumbra volumes and provides AIF/VOF graphs with reanalysis options for acute stroke hemodynamic assessment.
CTA vessel analysis and 2D/3D reconstruction software
CT angiography analysis for neurovascular imaging with 2D/3D vessel reconstruction, vessel-segment visualization, and quantitative vessel-density metrics to assist LVO assessment; performance for CTA-based detection is reported in documentation.
MRI nigrosome-1 quantification software
Diagnostic-aid software that analyzes susceptibility-weighted MR images and clinical metadata to detect and quantify nigrosome-1 features for Parkinsonism assessment. Internal performance reported with sensitivity and specificity metrics; documented server requirements for advanced modules are provided.
Automated intracranial hemorrhage triage software
Radiological triage and notification software that identifies suspected intracranial hemorrhage on non-contrast head CT and prioritizes cases for clinical review. Documented performance metrics and scanner-dependent input constraints are provided.
NCCT-based large vessel occlusion classification software
Automatic analysis of non-contrast CT and CTA images to classify suspected large vessel occlusion and predict the probable affected hemisphere to aid rapid triage, with documented performance examples and validation notes.
Automated ASPECTS scoring software
Automated computation of ASPECTS from non-contrast CT using a CNN algorithm to support ischemic stroke assessment; clinical investigation results and container/OS dependencies are documented.
CT perfusion analysis software
Automated CT perfusion analysis that produces color-coded perfusion maps, calculates core/penumbra volumes and provides AIF/VOF graphs with reanalysis options for acute stroke hemodynamic assessment.
CTA vessel analysis and 2D/3D reconstruction software
CT angiography analysis for neurovascular imaging with 2D/3D vessel reconstruction, vessel-segment visualization, and quantitative vessel-density metrics to assist LVO assessment; performance for CTA-based detection is reported in documentation.
Services
On-site or remote demonstrations of imaging AI solutions for clinical evaluation, validation and procurement discussions; demo requests collected via website forms.
On-site or remote demonstrations of imaging AI solutions for clinical evaluation, validation and procurement discussions; demo requests collected via website forms.
Expertise Areas
- Clinical AI for neuroimaging (acute neurovascular and neurodegenerative use cases)
- Stroke imaging analytics and triage workflows (NCCT, CTA, CTP)
- MRI biomarker extraction and quantitative neurodegeneration metrics
- Clinical performance evaluation and multicenter validation studies
Key Technologies
- Convolutional neural networks for medical imaging
- CT perfusion parameter estimation and AIF/VOF processing
- Automated hemorrhage detection from non-contrast CT
- LVO detection and hemisphere classification from NCCT/CTA
News & Updates
Company exhibition and booth presence at KCR 2026.
Company exhibition at KSIN 2026 spring meeting.
Company exhibition at KSEM 2026 annual meeting.
Announcement of regional medical device authorizations obtained for select products to support market expansion in Southeast Asia.
Report on technology evaluation outcomes and IPO preparation steps.
Memorandum of understanding to validate stroke AI technology with a national university hospital in Thailand.
Company exhibition and booth presence at KCR 2026.
Company exhibition at KSIN 2026 spring meeting.
Company exhibition at KSEM 2026 annual meeting.
Announcement of regional medical device authorizations obtained for select products to support market expansion in Southeast Asia.
Report on technology evaluation outcomes and IPO preparation steps.
Memorandum of understanding to validate stroke AI technology with a national university hospital in Thailand.